Browsing by Subject "antiglaucoma drugs"
Now showing items 1-1 of 1
-
Use of Topical Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated with Antiglaucoma Medications
(Mary Ann Liebert, Inc, 2017)Purpose: Chronic use of topical hypotensive therapies in glaucoma patients leads to chronic inflammation of the ocular surface, which decreases the success rate of long-term glaucoma management. The aim of this study is ...